CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Femtobiomed Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Femtobiomed Inc
D-510, 700, Pangyo-ro, Bundang-gu
Phone: +82 316288158p:+82 316288158 SEONGNAM, 13516  South Korea Ticker: 327610327610
Business Summary
Femtobiomed Inc. is a Korea-based company principally work on the research and development of natural science and engineering. The Company is engaged in the development and manufacture of anticancer vaccines through its platform called CELLSHOT.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Sang HyeonLee 51 11/30/2024
Director Ju HyeonChoi 53 11/30/2024 12/15/2022

General Information
Number of Employees: 12 (As of 12/31/2023)
Outstanding Shares: 8,441,630 (As of 11/20/2024)
Shareholders: 649
Stock Exchange: KON
Fax Number: +82 317079501


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 27, 2025